COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis

BACKGROUND AND OBJECTIVES: There are limited data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine reactogenicity in persons with multiple sclerosis (PwMS) and how reactogenicity is affected by disease-modifying therapies (DMTs). The objective of this retrospective cross-secti...

Descripción completa

Detalles Bibliográficos
Autores principales: Briggs, Farren Basil Shaw, Mateen, Farrah J., Schmidt, Hollie, Currie, Keisha M., Siefers, Heather M., Crouthamel, Slavka, Bebo, Bruce F., Fiol, Julie, Racke, Michael K., O'Connor, Kevin C., Kolaczkowski, Laura G., Klein, Phyllis, Loud, Sara, McBurney, Robert Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579248/
https://www.ncbi.nlm.nih.gov/pubmed/34753828
http://dx.doi.org/10.1212/NXI.0000000000001104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579248/
https://www.ncbi.nlm.nih.gov/pubmed/34753828
http://dx.doi.org/10.1212/NXI.0000000000001104

Ejemplares similares